The potential for mRNA goes well beyond the COVID-19 vaccine. With the support of the EU-funded MOSaIC project, one research centre in Poland is conducting cutting-edge research in the field, paving the way for new treatments against diseases such as cancer, Alzheimer’s and genetic conditions.
It was assumed that viruses spread as independent particles called virions. The EU-funded Vis-a-Vis project used social evolution concepts to study viral transmission, showing how viral particles compete and collaborate with one another. An improved understanding of virus-virus interactions paves the way for a new generation of treatments.
Understanding how the brain regulates bodily functions is critical for tackling metabolic disorders and neurodegenerative diseases. The EU-funded WATCH project is shedding light on the molecular mechanisms that underpin this process. The work supports novel therapies that could benefit citizens affected by Alzheimer’s disease, diabetes and COVID-19.
When COVID-19 was declared a global pandemic by the WHO, an EU funded research project immediately stepped up to the plate. BioExcel, one of Europe's leading centres for computational biomolecular research, gave priority access to its supercomputing facilities and cutting-edge software. This will help researchers and innovators across Europe in the fight against coronavirus.
The scientific community is expected to be prepared for and react promptly to emerging diseases by funding research and development. But to do so, it needs the unyielding and coordinated support from funding organisations. GloPID-R, an EU-funded global network, leads the way in helping ensure that the fight against all pandemics, present and future, is effective, rapid and leaves no one behind.
Developing a vaccine is a time-consuming and complex process. But as the current global pandemic has made abundantly clear, time is of the essence. That is why a group of EU-funded researchers launched a platform that provides services, support, networking, and training to help accelerate the development of important vaccines, including one for COVID-19.
Engineers are racing to replace silicon in electronics with a more responsive and energy-efficient alternative. EU-funded researchers have designed new devices with potential applications in communications, Internet of Things technology, and even in detecting coronavirus.
Emerging viruses pose a serious threat to global public health. EU-funded research is helping to advance our understanding of how infectious diseases evolve and adapt genetically, informing our efforts to develop an effective response. Researchers have already applied these new methods to several public health crises, including COVID-19.
Generating safe antigens to induce immunity is one of several key steps in vaccine production. Purification is another, and it is typically a complex process. EU-funded researchers have designed a way to simplify the process, boost yields, limit waste and reduce costs, in a bid to help make more doses available more affordably.
EU-funded researchers have developed an ultrasensitive test to rapidly, accurately and cost-effectively diagnose disease, underpinned by innovative biosensing technology that could help combat the COVID-19 pandemic, HIV and cancer.
